Your browser doesn't support javascript.
loading
IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer.
Wong, Jeffrey L; Smith, Patrick; Angulo-Lozano, Juan; Ranti, Daniel; Bochner, Bernard H; Sfakianos, John P; Horowitz, Amir; Ravetch, Jeffrey V; Knorr, David A.
Afiliação
  • Wong JL; Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065.
  • Smith P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Angulo-Lozano J; Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065.
  • Ranti D; Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065.
  • Bochner BH; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Sfakianos JP; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Horowitz A; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Ravetch JV; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Knorr DA; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Proc Natl Acad Sci U S A ; 120(35): e2306782120, 2023 08 29.
Article em En | MEDLINE | ID: mdl-37607227

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Interleucina-15 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Interleucina-15 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2023 Tipo de documento: Article